ASSOCIATED FACTORS TO UPPER GASTROINTESTINAL BLEEDING IN PATIENTS WITH ULCEROPEPTIC DISEASE. GASTROENTEROLOGY SERVICE, CHMDrAAM. JANUARY 1999 - MARCH 2001.
Introduction. Ulceropeptic disease is a very common clinical problem. In developed countries. the risk of acquiring this disease throughout life is 5 - 10 %. NSAID'~ are the most important risk factors for the development of bleeding.
Methodology. A not matched retrospective case - control study was made with a sample of 214 patients, who consulted the Gastroenterology Service of the Complejo Hospitalario Metropolitano, between January 1999 and March 2001, and who had a previous diagnosis of gastric or duodenal ulcer, with or without a history of upper GI bleeding. Data was obtained by inquest and analyzed to get the values of X2 and OR (confusing factors were adjusted according to Mantel - Haenszel's method) with their corresponding confidence interval.
Results. Patients with ulceropeptic disease that used NSAIDs had a risk 2.43 times higher of upper gastrointestinal bleeding than patients who did not used them (CI 95 % 1.34 - 4.41). When studying age groups, in the group 51 - 75 years we found an OR =2.74 (CI 95 % 1.23 - 6.13) and in the group over 75 years the OR =6.60 (CI 95 % 2.01 - 21.67).
Discussion. As in the reviewed Iiterature, we found that NSAIDs are a risk factor for the appearance of upper GI bleeding. We also found that age is an important risk factor, observing that as age increases so does the OA.
Downloads
Download data is not yet available.
References
- Sonneberg A, EverhartJE. Prevalence 01 sell-reported peptic ulcer in the United States. Am J Public Health 1996; 86:200-5.
- Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med 1994;331 :717-27.
- Jensen DM, Cheng S, Kovacs TO, et al. A controlled study 01 ranitidine lor the prevention 01 recurrent hemorrhage Irom duodenal ulcer. N Engl J Med 1994;330:382-6.
- Wara P, Stodkilde H. Bleeding pattern belore admission as guideline lor emergency endoscopy. Scand J Gastroenterol 1985;20:72-8.-
- Jensen DM, Machicado GA. Diagnosis and treatment 01 severe hematochezia. The role 01 urgent colonoscopy alter purge. Gastroenterology 1988;95:1569-74.
- Wilcox CM, Alexander LN, Cotsonis GA, Clark WS. Nonsteroidal antiinllammatory drugs are associated with both upper and lower gastrointestinal bleeding. Dig Dis Sci 1997; 42:990-7.
- Piper DW, Mclntosh ,IH, Ariotti DE, Fenton BH, MacLenan R. Analgesic ingestion and chronic peptic ulcer. Gastroenterology 1981; 80: 427-32.
- Goldstein JL, Silverstein FE, Agrawal NM, et al. Reduced risk 01 upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor. Am J Gastroenterol 2000; 95: 16881-90.
- Collins AJ, Du Toit JA. Upper gastrointestinal lindings and laecal occult blood in patients with rheumatic diseases taking nonsteroidal antiinllamatory drugs. Br J Rheumatol1987; 6: 295 8.
- Gabriel SE, Jaakkimainen L, Bombardier C. Risk lor serious gastrointestinal complications related to use 01 nonsteroidal anti inllammatory drugs. A meta-analysis. Ann Intern Med 1991; 115: 787-96.
- Hauge T, Persson J, Sjolund K. Neuropeptides in the duodenal mucosa 01 chronic alcoholic heavy drinkers. Alcohol Alcohol 2001 ; 36: 213-8.
- Weil J, Langman MJ, Wainwright P, Lawson DH, et al. Peptic Ulcer bleeding: Accessory risk lactors and interactions with non steroidal anti-inllammatory drugs. Gut 2000; 46: 27-31.
- Smalley WE; Ray WA; Daugherty JR; Griffin MR No association between calcium channel blocker use and conlirmed bleeding peptic ulcer disease. Am ,1 Epidemiol 1998; 148: 350-4.
